688065 logo

Cathay Biotech Inc. Stock Price

SHSE:688065 Community·CN¥36.1b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

688065 Share Price Performance

CN¥0
-38.80 (-100.00%)
CN¥0
-38.80 (-100.00%)
Price CN¥0

688065 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with proven track record.

2 Risks
2 Rewards

Cathay Biotech Inc. Key Details

CN¥3.3b

Revenue

CN¥2.3b

Cost of Revenue

CN¥1.0b

Gross Profit

CN¥413.3m

Other Expenses

CN¥594.5m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 24, 2026
0.82
30.65%
18.08%
1.3%
View Full Analysis

About 688065

Founded
2000
Employees
1764
CEO
Xiucai Liu
WebsiteView website
www.cathaybiotech.com

Cathay Biotech Inc., together with its subsidiaries, engages in the research, development, production, and sale of bio-based materials in China and internationally. The company offers biological long-chain diacids, including sebacic acid and octadecanedioic acid; bio-based polyamides; and bio-based pentamethylene diamine under the TERRYL and ECOPENT brands. It also provides digital solutions for electrification, automation, and digitization for biological manufacturing. The company’s products are used in textiles, pharmaceuticals, perfumes, automobiles, electronic appliances, consumer goods, engineering materials, and other industries. It exports its products. The company was incorporated in 2000 and is headquartered in Shanghai, China.

Recent 688065 News & Updates

Recent updates

No updates